Waverly Advisors LLC Raises Holdings in Infosys Limited (NYSE:INFY)

Waverly Advisors LLC grew its position in shares of Infosys Limited (NYSE:INFY) by 1.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 259,146 shares of the technology company’s stock after buying an additional 3,896 shares during the period. Waverly Advisors LLC’s holdings in Infosys were worth $5,680,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in INFY. Sierra Ocean LLC purchased a new position in shares of Infosys during the 4th quarter valued at $29,000. Farther Finance Advisors LLC lifted its position in shares of Infosys by 69.7% during the 4th quarter. Farther Finance Advisors LLC now owns 3,115 shares of the technology company’s stock valued at $68,000 after buying an additional 1,279 shares during the last quarter. Principal Securities Inc. lifted its position in shares of Infosys by 210.1% during the 4th quarter. Principal Securities Inc. now owns 4,822 shares of the technology company’s stock valued at $106,000 after buying an additional 3,267 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Infosys during the 4th quarter valued at $132,000. Finally, Jones Financial Companies Lllp lifted its position in shares of Infosys by 15.9% during the 4th quarter. Jones Financial Companies Lllp now owns 7,520 shares of the technology company’s stock valued at $165,000 after buying an additional 1,030 shares during the last quarter. Hedge funds and other institutional investors own 16.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. BMO Capital Markets dropped their price objective on Infosys from $25.00 to $18.00 and set a “market perform” rating on the stock in a report on Monday, April 21st. Susquehanna raised Infosys from a “negative” rating to a “neutral” rating and set a $17.00 price objective on the stock in a report on Monday, April 14th. The Goldman Sachs Group cut Infosys from a “buy” rating to a “neutral” rating and set a $17.90 price objective on the stock. in a report on Monday, April 21st. CLSA raised Infosys from a “hold” rating to an “outperform” rating in a report on Friday, March 7th. Finally, Investec raised Infosys from a “sell” rating to a “buy” rating in a report on Friday, April 18th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $17.48.

Infosys Stock Performance

Shares of INFY opened at $18.24 on Wednesday. The stock has a market capitalization of $75.55 billion, a price-to-earnings ratio of 23.09, a price-to-earnings-growth ratio of 3.50 and a beta of 0.98. The stock’s 50-day simple moving average is $17.69 and its 200 day simple moving average is $20.39. Infosys Limited has a 52-week low of $15.82 and a 52-week high of $23.63.

Infosys (NYSE:INFY) last announced its earnings results on Thursday, April 17th. The technology company reported $0.20 earnings per share for the quarter, topping analysts’ consensus estimates of $0.19 by $0.01. The business had revenue of $4.79 billion for the quarter, compared to analyst estimates of $420.69 billion. Infosys had a return on equity of 31.60% and a net margin of 17.28%. During the same period in the prior year, the company earned $0.23 EPS. On average, research analysts forecast that Infosys Limited will post 0.74 earnings per share for the current fiscal year.

Infosys Profile

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.